Drugs / rFIX
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01027364 | Dec 2009 → Jul 2012 | severe hemophilia B | Bioverativ Therapeutics Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rFIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01027364 ↗ |
| Modality | Protein / enzyme biologic | “comparative sequential pharmacokinetic assessments of recombinant factor IX and rFIXFc” PMID 24304002 ↗ Dec 2013 |